title: EASD diabetes technology meeting: medical associations are on track.
abstract: The first diabetes technology meeting organized by the European Diabetes Association covers the range from regulatory aspects, patient safety, about registries to clinical studies. After an intensive discussion about the evidence required for registration and reimbursement on new medical devices and in vitro diagnostics it becomes clear that more and better clinical trials will be required in the future. This was also highlighted by representatives of the American Diabetes Association. The 2 associations will be active in this field of research by a joint committee. This meeting is intended not to become a large-scale meeting focused on education but to provide a platform for an open discussion of experts involved in all areas that are relevant to achieve a meaningful usage of diabetes technology.
authors.affiliation: Science & Co, Düsseldorf, Germany l.heinemann@science-co.com.
authors.forename: Lutz
authors.initials: L
authors.lastname: Heinemann
mesh_terms: D001786:Blood Glucose / Q000032:analysis*; D015190:Blood Glucose Self-Monitoring / Q000295:instrumentation* / Q000592:standards*; D003920:Diabetes Mellitus / Q000097:blood; D005385:Fingers; D006801:Humans; D011934:Reagent Strips; D015203:Reproducibility of Results
chemical_list: D001786:Blood Glucose; D011934:Reagent Strips
keywords: artificial pancreas; blood glucose meters; continuous glucose monitoring; diabetes technology; insulin pumps; regulations